1,183
Views
0
CrossRef citations to date
0
Altmetric
Infectious Diseases

Diagnostic value of metagenomic next-generation sequencing of lower respiratory tract specimen for the diagnosis of suspected Pneumocystis jirovecii pneumonia

ORCID Icon, , , , &
Article: 2232358 | Received 03 May 2023, Accepted 23 Jun 2023, Published online: 04 Jul 2023

References

  • Roux A, Gonzalez F, Roux M, et al. Update on pulmonary Pneumocystis jirovecii infection in non-HIV patients. Med Mal Infect. 2014;44(5):1–10. doi: 10.1016/j.medmal.2014.01.007.
  • Rego de Figueiredo I, Vieira Alves R, Drummond Borges D, et al. Pneumocystosis pneumonia: a comparison study between HIV and non-HIV immunocompromised patients. Pulmonology. 2019;25(5):271–274. doi: 10.1016/j.pulmoe.2019.04.003.
  • Thomas CFJr, Limper AH. Pneumocystis pneumonia. N Engl J Med. 2004;350(24):2487–2498. doi: 10.1056/NEJMra032588.
  • Bateman M, Oladele R, Kolls JK. Diagnosing Pneumocystis jirovecii pneumonia: a review of current methods and novel approaches. Med Mycol. 2020;58(8):1015–1028. doi: 10.1093/mmy/myaa024.
  • Azoulay E, Bergeron A, Chevret S, et al. Polymerase chain reaction for diagnosing pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates. Chest. 2009;135(3):655–661. doi: 10.1378/chest.08-1309.
  • Fillaux J, Malvy S, Alvarez M, et al. Accuracy of a routine real-time PCR assay for the diagnosis of Pneumocystis jirovecii pneumonia. J Microbiol Methods. 2008;75(2):258–261. doi: 10.1016/j.mimet.2008.06.009.
  • Karageorgopoulos DE, Qu JM, Korbila IP, et al. Accuracy of beta-D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis. Clin Microbiol Infect. 2013;19(1):39–49. doi: 10.1111/j.1469-0691.2011.03760.x.
  • Koo S, Baden LR, Marty FM. Post-diagnostic kinetics of the (1 –> 3)-beta-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia. Clin Microbiol Infect. 2012;18(5):E122–E127. doi: 10.1111/j.1469-0691.2012.03777.x.
  • Li WJ, Guo YL, Liu TJ, et al. Diagnosis of pneumocystis pneumonia using serum (1-3)-beta-D-Glucan: a bivariate meta-analysis and systematic review. J Thorac Dis. 2015;7(12):2214–2225.
  • Peng JM, Du B, Qin HY, et al. Metagenomic next-generation sequencing for the diagnosis of suspected pneumonia in immunocompromised patients. J Infect. 2021;82(4):22–27. doi: 10.1016/j.jinf.2021.01.029.
  • Shi Y, Peng JM, Qin HY, et al. Metagenomic next-generation sequencing: a promising tool for diagnosis and treatment of suspected pneumonia in rheumatic patients with acute respiratory failure: retrospective cohort study. Front Cell Infect Microbiol. 2022;12:941930. doi: 10.3389/fcimb.2022.941930.
  • Wilson MR, Sample HA, Zorn KC, et al. Clinical metagenomic sequencing for diagnosis of meningitis and encephalitis. N Engl J Med. 2019;380(24):2327–2340. doi: 10.1056/NEJMoa1803396.
  • Chiu CY, Miller SA. Clinical metagenomics. Nat Rev Genet. 2019;20(6):341–355. doi: 10.1038/s41576-019-0113-7.
  • Wang D, Fang S, Hu X, et al. Metagenomic next-generation sequencing is highly efficient in diagnosing Pneumocystis Jirovecii pneumonia in the immunocompromised patients. Front Microbiol. 2022;13:913405. doi: 10.3389/fmicb.2022.913405.
  • Jiang J, Bai L, Yang W, et al. Metagenomic next-generation sequencing for the diagnosis of Pneumocystis jirovecii pneumonia in non-HIV-infected patients: a retrospective study. Infect Dis Ther. 2021;10(3):1733–1745. doi: 10.1007/s40121-021-00482-y.
  • Lagrou K, Chen S, Masur H, et al. Pneumocystis jirovecii disease: basis for the revised EORTC/MSGERC invasive fungal disease definitions in individuals without human immunodeficiency virus. Clin Infect Dis. 2021;72(Suppl 2):S114–S120. doi: 10.1093/cid/ciaa1805.
  • Bartlett JG, Breiman RF, Mandell LA, et al. Community-acquired pneumonia in adults: guidelines for management. The infectious diseases Society of America. Clin Infect Dis. 1998;26(4):811–838. doi: 10.1086/513953.
  • Meyer KC, Raghu G, Baughman RP, et al. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 2012;185(9):1004–1014. doi: 10.1164/rccm.201202-0320ST.
  • Amar Y, Lagkouvardos I, Silva RL, et al. Pre-digest of unprotected DNA by benzonase improves the representation of living skin bacteria and efficiently depletes host DNA. Microbiome. 2021;9(1):123. doi: 10.1186/s40168-021-01067-0.
  • Miller S, Naccache SN, Samayoa E, et al. Laboratory validation of a clinical metagenomic sequencing assay for pathogen detection in cerebrospinal fluid. Genome Res. 2019;29(5):831–842. doi: 10.1101/gr.238170.118.
  • Li H, Gao H, Meng H, et al. Detection of pulmonary infectious pathogens from lung biopsy tissues by metagenomic next-generation sequencing. Front Cell Infect Microbiol. 2018;8:205. doi: 10.3389/fcimb.2018.00205.
  • Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for illumina sequence data. Bioinformatics. 2014;30(15):2114–2120. doi: 10.1093/bioinformatics/btu170.
  • Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754–1760. doi: 10.1093/bioinformatics/btp324.
  • Fiorini N, Lipman DJ, Lu Z. Towards PubMed 2.0. ELife. 2017;6:e28801. doi: 10.7554/eLife.28801.
  • Gu W, Deng X, Lee M, et al. Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids. Nat Med. 2021;27(1):115–124. doi: 10.1038/s41591-020-1105-z.
  • Liu W, Li M, Xu Y, et al. Evaluation of the performance of a multiplex real-time PCR assay for the identification of Aspergillus, Cryptococcus neoformans, and Pneumocystis jirovecii simultaneously from sputum in multicenter. Infect Drug Resist. 2022;15:6009–6017. doi: 10.2147/IDR.S379043.
  • Sun R, Lv D, Xiao M, et al. Diagnostic accuracy of the 1,3-beta-D-glucan test and lactate dehydrogenase for pneumocystis pneumonia in non-HIV patients. Sci Rep. 2021;11(1):9226. doi: 10.1038/s41598-021-88729-z.
  • Maini R, Henderson KL, Sheridan EA, et al. Increasing Pneumocystis pneumonia, England, UK, 2000–2010. Emerg Infect Dis. 2013;19(3):386–392. doi: 10.3201/eid1903.121151.
  • Zheng Y, Qiu X, Wang T, et al. The diagnostic value of metagenomic NEXT-GENERATION sequencing in lower respiratory tract infection. Front Cell Infect Microbiol. 2021;11:694756. doi: 10.3389/fcimb.2021.694756.
  • Mitchell SL, Simner PJ. Next-Generation sequencing in clinical microbiology: are we there yet? Clin Lab Med. 2019;39(3):405–418. doi: 10.1016/j.cll.2019.05.003.
  • Alanio A, Hauser PM, Lagrou K, et al. ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother. 2016;71(9):2386–2396. doi: 10.1093/jac/dkw156.
  • Liu Y, Zheng K, Liu Y, et al. Pneumocystis jirovecii pneumonia in patients with nephrotic syndrome: application of lymphocyte subset analysis in predicting clinical outcomes. Can J Infect Dis Med Microbiol. 2020;2020:4631297. doi: 10.1155/2020/4631297.
  • Zhang F, Chen J, Huang H, et al. Application of metagenomic next-generation sequencing in the diagnosis and treatment guidance of Pneumocystis jirovecii pneumonia in renal transplant recipients. Eur J Clin Microbiol Infect Dis. 2021;40(9):1933–1942. doi: 10.1007/s10096-021-04254-x.
  • Homayouni MM, Rostami A, Gholizadeh H, et al. Comparison of three cost effective staining methods for detection of Pneumocystis jirovecii. J Parasit Dis. 2017;41(1):298–301. doi: 10.1007/s12639-016-0776-3.
  • Azar MM, Slotkin R, Abi-Raad R, et al. Gomori methenamine silver stain on bronchoalveolar lavage fluid is poorly sensitive for diagnosis of Pneumocystis jiroveci pneumonia in HIV-Negative immunocompromised patients and may lead to missed or delayed diagnoses. Arch Pathol Lab Med. 2020;144:1003–1010.
  • Wood BR, Komarow L, Zolopa AR, et al. Test performance of blood beta-glucan for Pneumocystis jirovecii pneumonia in patients with AIDS and respiratory symptoms. AIDS. 2013;27(6):967–972. doi: 10.1097/QAD.0b013e32835cb646.
  • Morjaria S, Frame J, Franco-Garcia A, et al. Clinical performance of (1,3) Beta-D glucan for the diagnosis of Pneumocystis pneumonia (PCP) in cancer patients tested with PCP polymerase chain reaction. Clin Infect Dis. 2019;69(8):1303–1309. doi: 10.1093/cid/ciy1072.
  • Li J, Li J, Yu Y, et al. Pneumocystis pneumonia and rheumatic disease: diagnostic potential of circulating microbial cell-free DNA sequencing. Rheumatol Adv Pract. 2022;6(1):rkab105.
  • Zhang Y, Ai JW, Cui P, et al. A cluster of cases of pneumocystis pneumonia identified by shotgun metagenomics approach. J Infect. 2019;78(2):158–169. doi: 10.1016/j.jinf.2018.08.013.
  • Meena DS, Kumar D. Candida pneumonia: an innocent bystander or a silent killer? Med Princ Pract. 2022;31(1):98–102. doi: 10.1159/000520111.
  • Raro OHF, Gallo SW, Ferreira CAS, et al. Carbapenem-resistant Acinetobacter baumannii contamination in an intensive care unit. Rev Soc Bras Med Trop. 2017;50(2):167–172. doi: 10.1590/0037-8682-0329-2016.
  • Collingwood A, Blostein F, Seekatz AM, et al. Epidemiological and microbiome associations between Klebsiella pneumoniae and vancomycin-resistant enterococcus colonization in intensive care unit patients. Open Forum Infect Dis. 2020;7(1):ofaa012. doi: 10.1093/ofid/ofaa012.